Science Explorer Back to mapMap

Most cited papers from Morphotek (United States)

What are the most cited papers from Morphotek (United States)?

The most cited paper from Morphotek (United States) is "Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance" (Daniel John O'Shannessy, Gordon H. Yu, Robert Smale et al., 2012), with 242 citations. Next come "Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers" (203) and "Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin." (189).

Showing 50 of 89 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance Daniel John O'Shannessy, Gordon H. Yu, Robert Smale et al. · Oncotarget Open access 29 Apr 2012 242
2 Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers Raffit Hassan, Steven J. Cohen, Martin D. Phillips et al. · Clinical Cancer Research Open access 29 Oct 2010 203
3 Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin. Raffit Hassan, Wolfgang Ebel, Eric Routhier et al. · PubMed Open access 19 Dec 2007 189
4 Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma Raffit Hassan, Hedy Lee Kindler, Thierry Marie Jahan et al. · Clinical Cancer Research Open access 18 Sep 2014 184
5 Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease Daniel John O'Shannessy, Elizabeth Brooke Somers, Julia D. Maltzman et al. · SpringerPlus Open access 28 Sep 2012 158
6 Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration Brian E. Tomkowicz, Katherine A. Rybinski, Brian Thomas Foley et al. · Proceedings of the National Academy of Sciences Open access 6 Nov 2007 158
7 Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer Deborah Kay Armstrong, Allen J. White, Susan C. Weil et al. · Gynecologic Oncology 6 Mar 2013 151
8 Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors Brian M. Necela, Jennifer A. Crozier, Cathy A. Andorfer et al. · PLoS ONE Open access 27 Mar 2015 149
9 Investigation of the Impact of Substrate Selection on In Vitro Organic Anion Transporting Polypeptide 1B1 Inhibition Profiles for the Prediction of Drug-Drug Interactions Saki Izumi, Yoshitane Nozaki, Kazuya Maeda et al. · Drug Metabolism and Disposition 21 Nov 2014 144
10 Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Wolfgang Ebel, Eric Routhier, Brian Thomas Foley et al. · PubMed Open access 9 Mar 2007 138
11 Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures Niklas K. Finnberg, Prashanth Ravishankar Gokare, Avital Lev et al. · Oncotarget Open access 5 Aug 2017 137
12 Expression of Folate Receptor-α (FRA) in Gynecologic Malignancies and its Relationship to the Tumor Type Daniel John O'Shannessy, Elizabeth Brooke Somers, Robert Smale et al. · International Journal of Gynecological Pathology 22 Mar 2013 110
13 Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression Akira Kurosaki, Kosei Hasegawa, Tomomi Kato et al. · International Journal of Cancer Open access 23 Nov 2015 107
14 Bioconjugation by Native Chemical Tagging of C–H Bonds Qianghui Zhou, Jinghan Gui, Chung‐Mao Pan et al. · Journal of the American Chemical Society Open access 19 Aug 2013 107
15 MORAb-202, an Antibody–Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity Xin Cheng, Jing Li, Keigo Tanaka et al. · Molecular Cancer Therapeutics 27 Sep 2018 94
16 Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors Mark Fairweather, Vinod P. Balachandran, George Z. Li et al. · Annals of Surgery Open access 27 Apr 2017 89
17 Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling Brian E. Tomkowicz, Kathy Rybinski, Denise Sebeck et al. · Cancer Biology & Therapy Open access Jun 2010 87
18 Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy Raffit Hassan, Charles Schweizer, Kun F. Lu et al. · Lung Cancer Open access 10 Sep 2009 86
19 Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed Daniel Christian Christoph, Bernadette Reyna Asuncion, Biftu Hassan et al. · Journal of Thoracic Oncology Open access 14 Dec 2012 84
20 Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy Evelyn Despierre, Sandrijne Lambrechts, Karin Leunen et al. · Gynecologic Oncology 2 Apr 2013 76
21 Characterization of the Human Folate Receptor Alpha Via Novel Antibody-Based Probes Daniel John O'Shannessy, Elizabeth Brooke Somers, Earl F. Albone et al. · Oncotarget Open access 27 Dec 2011 73
22 Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers Daniel John O'Shannessy, Elizabeth Brooke Somers, Li-chong Wang et al. · Journal of Ovarian Research Open access 13 May 2015 72
23 Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk Xiaowei Chen, Joellen Weaver, Betsy A. Bove et al. · Human Molecular Genetics Open access 19 Jan 2008 71
24 A White Paper—Consensus and Recommendations of a Global Harmonization Team on Assessing the Impact of Immunogenicity on Pharmacokinetic Measurements Jeffrey M. Sailstad, Lakshmi S. Amaravadi, Adrienne Clements‐Egan et al. · The AAPS Journal Open access 28 Mar 2014 67
25 A First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid Tumors Luis Alberto Diaz, Christina Marie Coughlin, Susan C. Weil et al. · Clinical Cancer Research Open access 15 Nov 2014 60
26 Gene Expression Analysis of Tumor Spheroids Reveals a Role for Suppressed DNA Mismatch Repair in Multicellular Resistance to Alkylating Agents Giulio Francia, Shan Man, Beverly A. Teicher et al. · Molecular and Cellular Biology Open access 14 Jul 2004 59
27 The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity Jianmin Lin, Jared L. Spidel, Christopher Maddage et al. · Cancer Biology & Therapy Open access 4 Oct 2013 54
28 Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4 Daniel John O'Shannessy, Elizabeth Brooke Somers, Leslie M. Palmer et al. · Journal of Ovarian Research Open access 17 Apr 2013 52
29 Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature Katherine A. Rybinski, Hongxia Z. Imtiyaz, Barrie Mittica et al. · Oncotarget Open access 4 Jul 2015 51
30 Human antibodies for immunotherapy development generated via a human B cell hybridoma technology Jian Li et al. · Proceedings of the National Academy of Sciences Open access 27 Feb 2006 50
31 Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA–MORAb-003 Peter M Smith-Jones, Neeta Pandit‐Taskar, Wei Cao et al. · Nuclear Medicine and Biology Open access 19 Mar 2008 48
32 Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT) imaging Liza Lindenberg, Anish Thomas, Stephen Adler et al. · Oncotarget Open access 4 Feb 2015 47
33 Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging Marlène C.H. Hekman, Otto C. Boerman, Desirée L. Bos et al. · Molecular Pharmaceutics Open access 21 Aug 2017 44
34 Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream ® for Detecting (or Monitoring) the Expression of Folate Receptor Alpha Daniel John O'Shannessy, Darren W. Davis, Kenna Lynn Anderes et al. · Biomarker Insights Open access 2016 44
35 Small molecule schweinfurthins selectively inhibit cancer cell proliferation and mTOR/AKT signaling by interfering with trans-Golgi-network trafficking Xingfeng Bao et al. · Cancer Biology & Therapy Open access 2 Mar 2015 43
36 Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammation Paul Petrus, Tara L. Fernandez, Michelle Kwon et al. · EBioMedicine Open access Jun 2019 41
37 Site-Specific Conjugation to Native and Engineered Lysines in Human Immunoglobulins by Microbial Transglutaminase Jared L. Spidel, Benjamin Vaessen, Earl F. Albone et al. · Bioconjugate Chemistry 18 Aug 2017 41
38 Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins Daniel John O'Shannessy, Elizabeth Brooke Somers, Lakshmi Krupa Chandrasekaran et al. · Oncotarget Open access 16 Jun 2014 39
39 Rapid high-throughput cloning and stable expression of antibodies in HEK293 cells Jared L. Spidel, Benjamin Vaessen, Yin Yin Chan et al. · Journal of Immunological Methods Open access 25 Sep 2016 35
40 Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer Kenneth H. Kim, Danijela Jelovac, Deborah Kay Armstrong et al. · Gynecologic Oncology Open access 28 Nov 2015 35
41 Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven®): Combination with Anticancer Agents of Differing Mechanisms Makoto Asano, Junji Matsui, Murray J. Towle et al. · Anticancer Research 30 May 2018 34
42 Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications Eiji Kiyohara, Nicholas C. Donovan, Ling Takeshima et al. · Cancer Microenvironment Open access 17 Jun 2015 34
43 Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement James Bradford Kline, Rina Kennedy, Earl F. Albone et al. · Oncotarget Open access 7 Jul 2017 33
44 A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma Sandra P. D’Angelo, Omid Hamid, Ahmad A. Tarhini et al. · Investigational New Drugs Open access 11 Nov 2017 32
45 Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy Nicholas C. Nicolaides, Daniel J. Oâ€TMShannessy, Earl F. Albone et al. · Frontiers in Oncology Open access 13 Jun 2014 32
46 A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer Axel F. Grothey, Jonathan Strosberg, Lindsay Anne Renfro et al. · Clinical Cancer Research 30 Oct 2017 31
47 Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B Brian Drozdowski, Yuhong Zhou, Brad Kline et al. · Journal of Immune Based Therapies and Vaccines Open access Dec 2010 31
48 Development of124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin Ann‐Marie Chacko, Chunsheng Li, Madhura Nayak et al. · Journal of Nuclear Medicine Open access 13 Feb 2014 31
49 Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody In‐Soo Shin, Sang-Myung Lee, Hyung Sub Kim et al. · Nuclear Medicine and Biology Open access 9 Jul 2011 31
50 Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe Morgan Jouanneau, Brandon McClary, Jeremy Chris P. Reyes et al. · Bioorganic & Medicinal Chemistry Letters Open access 24 Feb 2016 29

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.